• Palisade Bio director Robert Baltera Jr. bought 45,000 common shares in open-market purchases.
• Purchases averaged about USD 1.99 per share, based on weighted-average prices reported.
• Baltera’s direct holding rose to 461,904 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-032884), on July 10, 2026, and is solely responsible for the information contained therein.